The at-risk registers in severe asthma (ARRISA) study: A cluster-randomised controlled trial examining effectiveness and costs in primary care

Thorax

Volumn 67, Issue 12, 2012, Pages 1052-1060

  Smith, Jane Rebecca ^a   Noble, Michael J ^b   Musgrave, Stanley ^a   Murdoch, Jamie ^c   Price, Gill M ^a   Barton, Garry R ^a   Windley, Jennifer ^b   Holland, Richard ^a   Harrison, Brian D W ^a   Howe, Amanda ^a   Price, David B ^d   Harvey, Ian ^a   Wilson, Andrew M ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b Acle Medical Centre   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d Research in Real Life Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; PREDNISOLONE; SHORT ACTING DRUG; STEROID; THEOPHYLLINE;

ACCIDENT; ARTICLE; ASTHMA; CHILD; CLINICAL PRACTICE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEATH; DISEASE EXACERBATION; DISEASE REGISTRY; DISEASE SEVERITY; DRUG MEGADOSE; EMERGENCY CARE; EVIDENCE BASED MEDICINE; GENERAL PRACTITIONER; HEALTH CARE COST; HOSPITALIZATION; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; NEBULIZER; PATIENT CARE; PATIENT IDENTIFICATION; PRESCHOOL CHILD; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; RISK ASSESSMENT; UNSPECIFIED SIDE EFFECT;

EID: 84869239758     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-202093     Document Type: Article

References (33)

1. British Thoracic Society & Scottish Intercollegiate Guideline Network. British guideline on the management of asthma. Thorax 2003;58(Suppl 1):i1-94.
2. Masoli M, Fabian D, Holt S, et al. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59:469-78. (Pubitemid 38580764)
3. Rabe KF, Adachi M, Lai CK, et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004;114:40-7. (Pubitemid 39022491)
4. Barnett SB, Nurmagambetov TA. Costs of asthma in the United States: 2002-2007. J Allergy Clin Immunol 2011;127:145-52.
5. Hoskins G, McCowan C, Neville RG, et al. Risk factors and costs associated with an asthma attack. Thorax 2000;55:19-24. (Pubitemid 30248774)
6. Vervloet D, Williams AE, Lloyd A, et al. Costs of managing asthma as defined by a dervied Asthma Control Test (TM) score in seven European countries. Eur Respir Rev 2006;15:17-23. (Pubitemid 47028413)
7. Sturdy PM, Victor CR, Anderson HR, et al. Psychological, social and health behaviour risk factors for deaths certified as asthma: a national case-control study. Thorax 2002;57:1034-9. (Pubitemid 35440762)
8. Wainwright NW, Surtees PG, Wareham NJ, et al. Psychosocial factors and incident asthma hospital admissions in the EPIC-Norfolk cohort study. Allergy 2007;62:554-60. (Pubitemid 46608357)
9. Yoon R, McKenzie DK, Miles DA, et al. Characteristics of attenders and nonattenders at an asthma education programme. Thorax 1991;46:886-90.
10. Gibson PG, Powell H, Coughlan J, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2002;(3): CD001117.
11. Smith JR, Mugford M, Holland R, et al. Psycho-educational interventions for adults with severe or difficult asthma: a systematic review. J Asthma 2007;44:219-41. (Pubitemid 46598153)
12. Sturdy PM, Butland BK, Anderson HR, et al. Deaths certified as asthma and use of medical services: a national case-control study. Thorax 2005;60:909-15. (Pubitemid 41598206)
13. Noble MJ, Smith JR, Windley J. A controlled retrospective pilot study of an 'at-risk asthma register' in primary care. Prim Care Respir J 2006;15:116-24.
14. NHS Employers Quality and Outcomes Framework. http://www.nhsemployers. org/PayAndContracts/GeneralMedicalServicesContract/QOF/Pages/ QualityOutcomesFramework.aspx (accessed 4 Apr 2011).
15. Communities and Local Government. The English Indices of Deprivation Report 2007. http://www.communities.gov.uk/publications/communities/ indiciesdeprivation07 (accessed 4 Apr 2011).
16. PRIMIS+ Morbidity Information Query and Export Syntax (MIQUEST) Software. http://www.primis.nhs.uk/index.php/services/information-services/miquest (accessed 4 Apr 2011).
17. Tattersfield AE, Postma DS, Barnes PJ, et al. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med 1999;160:594-9. (Pubitemid 29380678)
18. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83. (Pubitemid 17055592)
19. Campbell MK, Mollison J, Grimshaw JM. Cluster trials in implementation research: estimation of intracluster correlation coefficients and sample size. Stat Med 2001;20:391-9. (Pubitemid 32125129)
20. Altman DG, Dore CJ. Baseline comparisons in randomized clinical trials. Stat Med 1991;10:797-9.
21. Donner A, Klar N. Design and Analysis of Cluster Randomization Trials in Health Research. London: Arnold, 2000.
22. Curtis L. Unit Costs of Health and Social Care 2008. Canterbury: University of Kent Personal Social Services Research Unit, 2008.
23. Department of Health. National Schedule of Reference Costs 2007-08. London: Department of Health, 2009.
24. British Medical Association/Royal Pharmaceutical Society of Great Britain. British National Formulary (BNF) 55. London: Pharmaceutical Press, 2008.
25. The NHS Information Centre for Health and Social Care. Prescription Cost Analysis: England 2008. http://www.ic.nhs.uk/statistics-and-data-collections/ primary-care/prescriptions/prescription-cost-analysis-2008 (accessed 4 Apr 2011).
26. Bachmann MO, Fairall L, Clark A, et al. Methods for analyzing cost effectiveness data from cluster randomized trials. Cost Eff Resour Alloc 2007;5:12.
27. Reddel HK, Taylor DR, Bateman ED, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009;180:59-99.
28. Crane J, Pearce N, Burgess C, et al. Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol 1992;21:737-44.
29. Mitchell EA, Bland JM, Thompson JM. Risk factors for readmission to hospital for asthma in childhood. Thorax 1994;49:33-6. (Pubitemid 24118892)
30. Boyd M, Lasserson TJ, McKean MC, et al. Interventions for educating children who are at risk of asthma-related emergency department attendance. Cochrane Database Syst Rev 2009;(2):CD001290.
31. Tapp S, Lasserson TJ, Rowe B. Education interventions for adults who attend the emergency room for acute asthma. Cochrane Database Syst Rev 2007;(3):CD003000.
32. Lemmens KM, Nieboer AP, Huijsman R. A systematic review of integrated use of disease-management interventions in asthma and COPD. Respir Med 2009;103:670-91.
33. Griffiths C, Foster G, Barnes N, et al. Specialist nurse intervention to reduce unscheduled asthma care in a deprived multiethnic area: the east London randomised controlled trial for high risk asthma (ELECTRA). BMJ 2004;328:144.